,
                  executive director of hepatitis C support project, Santa
                  Barbara.
                  The 106th Congress ended in October with one major victory
                  and one major setback. We got the first piece of major federal
                  legislation with a title for hepatitis C virus (HCV). The HCV
                  title is in the children's health care act of 2000 which often
                  authorizes the Centers for Disease Control and Prevention (CDC)
                  to establish national surveillance of chronic hepatitis C and
                  education programs for health-care professionals and the
                  public. The next step is to get Congress to give the CDC money
                  specifically for the HCV surveillance and education program.
                  Within the same halls of Congress for Republican and
                  Democratic leadership joined forces to develop the children's
                  health care act, a planned national HCV Alert was dropped. The
                  commerce committee and Surgeon General David Satcher had
                  planned to send a letter to every American household alerting
                  the public to the risk of HCV. Satcher had previously declared
                  hepatitis C and epidemic and a "grave threat"
                  "to the American public's health. But when push came to
                  shove Satcher and the commerce committee backed down from
                  sending the letter, saying it could not go out because there
                  was no money to pay for the postage. As a result, what should
                  have been a sincere effort at public education will probably
                  remain on the Surgeon General's desk through the end of this
                  presidential administration.
                  The letter experience -- and the HCV title in the
                  children's bill -- is unfortunately characteristic of other
                  federal responses to the hepatitis C epidemic by this
                  administration. The food and drug administration has
                  repeatedly postponed a huge blood look back program to notify
                  people who had received the blood transfusions potentially
                  contaminated with hepatitis C virus. The looked back was
                  launched three years ago, but the original intent of the
                  advisory committee on blood safety and availability remains
                  only partially implemented.
                  There are several other examples of this neglectful
                  pattern. The Secretary of health and human services HHS
                  announced an HCV initiative in January 1998 that, in addition
                  to launching the looked back, gave the CDC responsibility for
                  general public education campaign on hepatitis C. The CDCs
                  budgets in recent years have included roughly $1 million a
                  year for public education on this disease. However, there is
                  little evidence of any of their general public education
                  efforts. A pilot public education program the CDC launched
                  into cities Washington and Chicago and fiscal year 1999 was
                  discontinued in fiscal year 2000 after spending only $70,000.
                  And recent work plans have mentioned only education
                  initiatives targeted to high-risk groups.
                  The department of Veterans Affairs (VA) announced a high
                  profile initiative on hepatitis C in January 1999 in response
                  to an estimated infection rate of 8 to 10 percent among
                  veterans. (Note from Lloyd. Vietnam era veteran have a 65
                  percent infection rate). Congress followed by providing the VA
                  an additional $350 million for hepatitis C testing and
                  treatment in fiscal year 2000. While 179,000 veterans have
                  already tested positive in the VA, the VA had stated it
                  expected to treat only 9.750 of them in fiscal year 2000. As
                  of the end the first half of the fiscal year 2000, only 1100
                  veterans had received treatment and only 39 million of its HCV
                  funds were spent. Although the VA's commitment to this
                  initiative seems sincere, its failure to implement it is
                  disturbing.
                  The CDC also has responsibility for surveillance of
                  infectious disease and for providing information on the
                  incidence and prevalence of disease in the population. Despite
                  the initiative announced that HHS Secretary in 1998, the CDC
                  has continued to instruct the states not to report cases of
                  chronic infection. In doing so, they have ignored
                  recommendations for surveillance for the Secretary's own
                  advisory committee on blood safety and availability and from
                  the council of state and territorial epidemiologists. Instead
                  the center has continued to use estimates of prevalence from
                  data collected in 1991, before an accurate blood tests for HCV
                  was available, and to rely on incident data from a few
                  "sentinel counties". There is no national
                  surveillance system that can accurately inform public health
                  officials about the incidence of prevalence of this infectious
                  disease in their communities.
                  I marvel at this administration's failure to notify the
                  public or respond with an effective screening or treatment
                  initiatives. An estimated 4 million Americans are infected
                  with HCV today -- most of them infected before a blood test
                  was available -- and at least 70 percent of these remain
                  unaware of their illness. A disease that is four times as
                  prevalent as AIDS, and that is projected within the decade to
                  kill more people each year than AIDS, seems to me to be
                  sufficient cause for major public education initiative.
                  The Secretary's advisory committee on blood safety and
                  availability summed it up when it stated in a resolution
                  adopted on Aug. 25th 2000:
                  "The committee believes that the public has not been
                  adequately informed of the risk factors of HCV and
                  approximately 4 million Americans may be infected with HCV,
                  many of whom are unaware of their infection."
                  "The committee feels that this possesses a threat to
                  the safety of the blood supply. Therefore, the committee
                  recommends that the Surgeon General send a letter to all U.S.
                  households, notifying the public about the risk factors for
                  HCV and appropriate testing treatment options."
                  And on a state level, in the fall of 2000, Gov. Gray Davis
                  signed California's first hepatitis C bill Polanco SB -- 1258.
                  The Bills started off with a $7 million price tag to implement
                  testing and education in the state of California. It was
                  reduced to 5 million, and then went to Gov. Davis desk at 2
                  million. Gov. Davis reduced it to 1.5 million; with half going
                  to veterans whom already have funds budgeted for hepatitis C.
                  Another portion was given to the Department of Corrections to
                  reproduce a report on hepatitis C.
                  Several years ago, the Department of Corrections gave back
                  significant funds for hepatitis C because it had failed to use
                  the monies. It is estimated that close to 50 percent of the
                  states incarcerated are infected with hepatitis C. The states
                  potentially infection will be lucky to see $500,000, which
                  amounts to about 1 dollar a patient for testing and education.
                  According to the CDC, 1.8 percent or 500,000, of
                  Californians have been exposed to the hepatitis C virus. Many
                  of the states experts agree, along with insurance actuaries,
                  that projected numbers from the CDC are low and that they are
                  actually closer to four percent of the population who have
                  been exposed to HCV or 1in 25, with 70 percent of the infected
                  unaware they carry the disease. This author, along with other
                  area public health officials, last spring participated in
                  several meetings in Sacramento with the Department of Health
                  Services in California on a hepatitis C strategic planning
                  committee. This plan outlines how teaching and education shall
                  be implemented with the state. This plan has yet to be put out
                  into final draft form after almost one year.
                  In 2000, there were approximately 16,000 people on the
                  liver transplant list in the U.S., with the majority of cases
                  caused by complications of HCV. Only 4500 received livers.
                  Experts predict, knowing the natural history of this disease
                  that the number awaiting the new livers will triple over the
                  next 10 years, with organ donations remaining the same. It is
                  clear to this author that, with an approximately $25,000 price
                  tag per patient and a 37 percent success rate for treatment,
                  that sometimes includes difficult side effects, officials are
                  slow to begin diagnosing patients. With no state or federal
                  funds available, many County officials and public official
                  departments find this overwhelming task to tackle. Patient
                  advocates would like to see a more aggressive effort to
                  educate the general public about risk factors in transmission
                  routes, encouraging and providing free testing, and
                  establishment of referral in case management services.
                  Last week, experts on hepatitis C converged in Santa
                  Barbara for a daylong educational event targeting health-care
                  providers. This event was organized by the back to life
                  Hepatitis support project, with co-sponsors Santa Barbara city
                  colleges continuing education department, Santa Barbara County
                  public health and County alcohol drug and mental health
                  services. Clearly the full arena of more than 100 shows the
                  interest in magnitude of this disease's impact on our
                  health-care system. Experts referred to the hepatitis C
                  epidemic as a tidal wave off the coast of California.
                  Also last week was the first successful meeting of the
                  hepatitis C task force, which was attended by representatives
                  from impacted agencies, health-care providers, and
                  community-based organizations and was held at the Santa
                  Barbara public health department. Attendees listen to speakers
                  from other organizations that have hepatitis C educational and
                  testing models already in place in other parts of the state.
                  The purpose of this task force is to set of a strategic plan
                  modeled after the state Department of Health Services plan to
                  implement testing, education, and management of hepatitis C
                  into existing services.